Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Isabel Cunningham MD

Isabel Cunningham MD

Adjunct Associate Research Scientist, Division of Hematology Oncology, Columbia University College of Physicians and Surgeons, New York, New York

With broad experience in both academic oncology and clinical research, Dr. Cunningham provides a crucial bridge between community and academic medicine. Dr. Cunningham received her AB from Bryn Mawr College and her MD from Yale University School of Medicine. Her postgraduate training included a fellowship in hematology-oncology and bone marrow transplant at Memorial Sloan-Kettering Cancer Center. Dr. Cunningham has held academic positions at Memorial Sloan-Kettering and several other universities, and she is currently conducting research at Columbia University. She has published extensively and has been a reviewer for Blood, Bone Marrow Transplantation, Experimental Hematology, and Leukemia & Lymphoma.

Positions:
Adjunct Associate Research Scientist, Columbia University

Degrees:
Bryn Mawr College, AB
Yale University School of Medicine, MD

Postgraduate Training:
Resident, Internal Medicine, Presbyterian Hospital, New York
Fellow, Hematology/Oncology, Memorial Sloan-Kettering Cancer Center

Board Certifications:
Internal medicine
Hematology

Clinical Interests:
Hematologic malignancies
Extramedullary Leukemia

Disclosures

Dr. Cunningham does not have any financial disclosures.

Recent Contributions to PracticeUpdate:

  1. ASCO 2016: Dr. Isabel Cunningham's Abstract Recommendations—Hematologic Malignancies
  2. Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
  3. Decision Analysis of Post-Remission Therapy in Cytogenetically Intermediate-Risk AML
  4. 2015 Top Stories in Oncology: 2015 Focus on Ph’+ ALL: Important Progress
  5. ASH 2015: Suggestions From Dr. Isabel Cunningham—Part II
  6. ASH 2015: Suggestions From Dr. Isabel Cunningham—Part I
  7. Follow-Up of Imatinib Plus Chemotherapy in Patients With Philadelphia Chromosome-Positive ALL
  8. Brentuximab Vedotin as Consolidation Therapy After Autologous Stem-Cell Transplantation in Patients With Hodgkin's Lymphoma
  9. 2014 Top Story of the Year: Immunotherapy
  10. 2014 Top Stories in Oncology: Leukemia

Most Read This Week

Recently Updated